Amylyx Pharmaceuticals (AMLX) Shares Outstanding (Entity) (2021 - 2026)
Amylyx Pharmaceuticals' Shares Outstanding (Entity) came in at 111.37 million for Q2 2026, up 24.9% from 89.16 million a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
For FY2025, Amylyx Pharmaceuticals' Shares Outstanding (Entity) was 109.88 million, up 60.1% from FY2024.
- Shares Outstanding (Entity) has increased in each of the last four years, with a four-year compound annual growth rate of 98.9% (FY2021 to FY2025).
- Going back by year, Shares Outstanding (Entity) was 68.63 million in FY2024 (+1.4%), 67.71 million in FY2023 (+1.8%), 66.51 million in FY2022 (+847.4%) and 7.02 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2021.
- Year-over-year, Shares Outstanding (Entity) has increased for 18 consecutive quarters, with growth averaging 29.3% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 1.1% in Q2 2024 to 847.4% in Q4 2022.
- Business Quant data shows AMLX's Shares Outstanding (Entity) at 111.03 million (Q1 2026), 109.88 million (Q4 2025) and 109.77 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Amylyx Pharmaceuticals | 3.24 Bn | 3.24 Bn | - | 111.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 111.37 Mn |
| Mar 31, 2026 | 111.03 Mn |
| Dec 31, 2025 | 109.88 Mn |
| Sep 30, 2025 | 109.77 Mn |
| Jun 30, 2025 | 89.16 Mn |
| Mar 31, 2025 | 89.08 Mn |
| Dec 31, 2024 | 68.63 Mn |
| Sep 30, 2024 | 68.55 Mn |
| Jun 30, 2024 | 68.08 Mn |
| Mar 31, 2024 | 67.98 Mn |
| Dec 31, 2023 | 67.71 Mn |
| Sep 30, 2023 | 67.51 Mn |
| Jun 30, 2023 | 67.35 Mn |
| Mar 31, 2023 | 67.10 Mn |
| Dec 31, 2022 | 66.51 Mn |
| Sep 30, 2022 | 58.53 Mn |
| Jun 30, 2022 | 58.53 Mn |
| Mar 31, 2022 | 57.86 Mn |
| Dec 31, 2021 | 7.02 Mn |
| Sep 30, 2021 | 6.80 Mn |
API Access
Amylyx Pharmaceuticals Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();